Abstract:Diabetic peripheral neuropathy (DPN) is the prevalent type of peripheral neuropathy; it primarily impacts extremity nerves. Its multifaceted nature makes the molecular mechanisms of diabetic neuropathy intricate and incompletely elucidated. Several types of post-translational modifications (PTMs) have been implicated in the development and progression of DPN, including phosphorylation, glycation, acetylation and SUMOylation. SUMOylation involves the covalent attachment of small ubiquitin-like modifier (SUMO) proteins to target proteins, and it plays a role in various cellular processes, including protein localization, stability, and function. While the specific relationship between high blood glucose and SUMOylation is not extensively studied, recent evidence implies its involvement in the development of DPN in type 1 diabetes. In this study, we investigated the impact of SUMOylation on the onset and progression of DPN in a type 2 diabetes model using genetically modified mutant mice lacking SUMOylation, specifically in peripheral sensory neurons (SNS-Ubc9-/-). Behavioural measurement for evoked pain, morphological analyses of nerve fibre loss in the epidermis, measurement of reactive oxygen species (ROS) levels, and antioxidant molecules were analysed over several months in SUMOylation-deficient and control mice. Our longitudinal analysis at 30 weeks post-high-fat diet revealed that SNS-Ubc9-/- mice exhibited earlier and more pronounced thermal and mechanical sensation loss and accelerated intraepidermal nerve fibre loss compared to control mice. Mechanistically, these changes are associated with increased levels of ROS both in sensory neuronal soma and in peripheral axonal nerve endings in SNS-Ubc9-/- mice. In addition, we observed compromised detoxifying potential, impaired respiratory chain complexes, and reduced levels of protective lipids in sensory neurons upon deletion of SUMOylation in diabetic mice. Importantly, we also identified mitochondrial malate dehydrogenase (MDH2) as a SUMOylation target, the activity of which is negatively regulated by SUMOylation. Our results indicate that SUMOylation is an essential neuroprotective mechanism in sensory neurons in type 2 diabetes, the deletion of which causes oxidative stress and an impaired respiratory chain, resulting in energy depletion and subsequent damage to sensory neurons.

Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes

Nitric Oxide Synthase Activity and Expression in Experimental Diabetic Neuropathy

Critical Role of Inducible Nitric Oxide Synthase in Degeneration of Retinal Capillaries in Mice with Streptozotocin-Induced Diabetes

Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy

Abstract 12692: Overexpression of Myocardial Inducible Nitric Oxide Synthase Exacerbates Cardiac Dysfunction and Beta-Adrenergic Desensitization in Streptozotocin-Induced Diabetic Mice

Hypoxia-inducible factor 1a protects peripheral sensory neurons from diabetic peripheral neuropathy by suppressing accumulation of reactive oxygen species

Downregulation of Neuronal Nitric Oxide Synthase (nnos) Within the Paraventricular Nucleus in Ins2akita-Type-1 Diabetic Mice Contributes to Sympatho-Excitation

Overexpression of Sirtuin 1 protein in neurons prevents and reverses experimental diabetic neuropathy.

Gene Expression Microarray Analysis of the Sciatic Nerve of Mice with Diabetic Neuropathy.

Reduced spinal microglial activation and neuropathic pain after nerve injury in mice lacking all three nitric oxide synthases

NAD+ Precursors Reverse Experimental Diabetic Neuropathy in Mice

A novel antihypoglycemic role of inducible nitric oxide synthase in liver inflammatory response induced by dietary cholesterol and endotoxemia

Endothelial Nitric Oxide Synthase-Dependent Tyrosine Nitration Of Prostacyclin Synthase In Diabetes In Vivo

Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy

Nitric Oxide as a Potential Bridge Between the Metabolic and Vascular Hypotheses of Diabetic Neuropathy

SUMOylation Modulates Reactive Oxygen Species (ROS) Levels and Acts as a Protective Mechanism in the Type 2 Model of Diabetic Peripheral Neuropathy

Inducible Nitric Oxide Synthase Has Divergent Effects on Vascular and Metabolic Function in Obesity.

Gene expression profiles of diabetic kidney disease and neuropathy in eNOS knockout mice: Predictors of pathology and RAS blockade effects

Enos Gene Therapy Exacerbates Hepatic Ischemia-Reperfusion Injury in Diabetes - A Role for Enos Uncoupling

Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain

Overexpression of Inducible Nitric Oxide Synthase in the Diabetic Heart Compromises Ischemic Postconditioning.